New supplement trial hopes to lift depression treatment
NCT ID NCT07416747
First seen Feb 23, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study tests whether a dietary supplement called GynMDD, taken alongside weekly talk therapy, can improve symptoms of mild to moderate depression more than therapy alone. About 168 adults aged 18 to 65 will take either the supplement or a placebo daily for 8 weeks and report their mood and digestive health. The goal is to see if the supplement provides extra relief and also affects gut bacteria.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Albert Chenevier 40 rue de Mesly
Créteil, 94010, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.